<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Approximately 30% of colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp> develop via a serrated <z:hpo ids='HP_0002664'>neoplasia</z:hpo> pathway, named for the pattern of crypts in the precursor <z:mpath ids='MPATH_491'>polyps</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>Molecular abnormalities consistently involve methylation of CpG islands [CpG island methylator phenotype (CIMP)] of low degree (CIMP-L) or high degree (CIMP-H), and activating mutations of the <z:chebi fb="0" ids="52290">mitogen</z:chebi>-activated protein kinase pathway components BRAF or KRAS </plain></SENT>
<SENT sid="2" pm="."><plain>Microsatellite instability (MSI) of a high level (MSI-H) is often present, allowing for a molecular classification of serrated pathway <z:mp ids='MP_0002038'>carcinoma</z:mp> as: (i) BRAF mutant/CIMP-H with either a) MSI-H or b) microsatellite stable (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MSS</z:e>); and (ii) KRAS mutant/CIMP-L/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MSS</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Precursor <z:mpath ids='MPATH_491'>polyps</z:mpath> include sessile serrated <z:mpath ids='MPATH_270'>adenoma</z:mpath> (SSA), characterized by proximal location, crypt architectural disturbance, and BRAF mutation </plain></SENT>
<SENT sid="4" pm="."><plain>Microvesicular hyperplasic <z:mpath ids='MPATH_491'>polyp</z:mpath> (MVHP) probably precedes the development of SSA, and borderline lesions between MVHP and SSA occur </plain></SENT>
<SENT sid="5" pm="."><plain>Cytological <z:mpath ids='MPATH_589'>dysplasia</z:mpath> in SSA portends advanced genetic abnormality and a high risk of progression to <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>The traditional serrated <z:mpath ids='MPATH_270'>adenoma</z:mpath> has a predilection for the left colon, tubulovillous architecture, eosinophilic cytoplasm, and frequent KRAS mutation </plain></SENT>
<SENT sid="7" pm="."><plain>Serrated <z:mp ids='MP_0000002'>morphology</z:mp> <z:mp ids='MP_0002038'>carcinoma</z:mp> is a new World Health Organization subtype with well-differentiated, mucinous or trabecular patterns </plain></SENT>
<SENT sid="8" pm="."><plain>It has frequent KRAS or BRAF mutations and a poor prognosis </plain></SENT>
<SENT sid="9" pm="."><plain>This review provides an insight into the histology and molecular mechanisms driving these serrated pathway lesions </plain></SENT>
</text></document>